A self-assembled affibody-PROTAC conjugate nanomedicine for targeted cancer therapy

Conjugate Cancer Therapy Targeted Therapy
DOI: 10.1007/s12274-024-6974-x Publication Date: 2024-09-07T09:02:19Z